SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,000 | -17.2% | 2,543 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $29,000 | -68.5% | 2,543 | -53.0% | 0.00% | -66.7% |
| Q3 2018 | $92,000 | +10.8% | 5,411 | -7.4% | 0.01% | +20.0% |
| Q2 2018 | $83,000 | +27.7% | 5,846 | +70.3% | 0.01% | +25.0% |
| Q1 2018 | $65,000 | -96.0% | 3,432 | -96.5% | 0.00% | -95.1% |
| Q4 2017 | $1,626,000 | +9.3% | 99,155 | +0.1% | 0.08% | +34.4% |
| Q3 2017 | $1,487,000 | – | 99,089 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |